Endocrinology & Metabolism
FDA Approves First Treatment for MCT8 Deficiency
The FDA approved tiratricol as the first treatment for peripheral thyrotoxicosis in MCT8 deficiency, targeting cardiovascular and metabolic manifestations rather than the disorder’s established neurologic disability.
Dr. Abu Bakar · October 4, 2026 · 6 min